NO895194D0 - Fremgangsmaate for fremstilling av piperidinderivater. - Google Patents
Fremgangsmaate for fremstilling av piperidinderivater.Info
- Publication number
- NO895194D0 NO895194D0 NO895194A NO895194A NO895194D0 NO 895194 D0 NO895194 D0 NO 895194D0 NO 895194 A NO895194 A NO 895194A NO 895194 A NO895194 A NO 895194A NO 895194 D0 NO895194 D0 NO 895194D0
- Authority
- NO
- Norway
- Prior art keywords
- preparing
- procedure
- piperide
- ingredients
- piperide ingredients
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK715988A DK715988D0 (da) | 1988-12-22 | 1988-12-22 | Etherifikation og dealkylering af piperidin-derivater samt intermediater |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO895194D0 true NO895194D0 (no) | 1989-12-21 |
| NO895194L NO895194L (no) | 1990-06-25 |
Family
ID=8149231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89895194A NO895194L (no) | 1988-12-22 | 1989-12-21 | Fremgangsmaate for fremstilling av piperidinderivater. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0374674A2 (no) |
| JP (1) | JPH02225464A (no) |
| AU (1) | AU4692789A (no) |
| CA (1) | CA2005354A1 (no) |
| DK (1) | DK715988D0 (no) |
| FI (1) | FI896095A0 (no) |
| IL (1) | IL92681A0 (no) |
| NO (1) | NO895194L (no) |
| PT (1) | PT92715A (no) |
| ZA (1) | ZA899779B (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL98757A (en) * | 1990-07-18 | 1997-01-10 | Novo Nordisk As | Piperidine derivatives their preparation and pharmaceutical compositions containing them |
| EP0755923B1 (en) * | 1995-01-23 | 2005-05-04 | Daiichi Suntory Pharma Co., Ltd. | Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor |
| AR001982A1 (es) * | 1995-02-06 | 1998-01-07 | Smithkline Beecham Plc | Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion |
| US5856493A (en) * | 1995-02-06 | 1999-01-05 | Smithkline Beecham Corporation | Process for making novel form of paroxeting hydrochloride anhydrate |
| JPH11505229A (ja) * | 1995-05-17 | 1999-05-18 | ノボ ノルディスク アクティーゼルスカブ | ４−アリール−ピペリジン誘導体を製造する方法 |
| WO1997009311A1 (de) * | 1995-09-07 | 1997-03-13 | F. Hoffmann-La Roche Ag | Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz |
| HU221921B1 (hu) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására |
| GB9623359D0 (en) * | 1996-11-09 | 1997-01-08 | Smithkline Beecham Plc | Novel process |
| GB9700690D0 (en) | 1997-01-15 | 1997-03-05 | Smithkline Beecham Plc | Novel process |
| WO1998045263A1 (en) * | 1997-04-07 | 1998-10-15 | Georgetown University | Analogs of cocaine |
| EA199901098A1 (ru) | 1997-05-29 | 2000-08-28 | Смитклайн Бичам Корпорейшн | Новый способ |
| AU3108097A (en) | 1997-06-10 | 1998-12-30 | Synthon B.V. | 4-phenylpiperidine compounds |
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| IT1308629B1 (it) * | 1999-02-23 | 2002-01-09 | Recordati Chem Pharm | Processo per la produzione di paroxetina. |
| IT1313702B1 (it) * | 1999-08-02 | 2002-09-09 | Chemi Spa | Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine. |
| GB9923540D0 (en) * | 1999-10-05 | 1999-12-08 | Smithkline Beecham Plc | Novel process |
| CA2433605A1 (en) * | 2001-01-04 | 2002-07-11 | Ferrer Internacional, S.A. | Process for preparing (.plusmn.) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine |
-
1988
- 1988-12-22 DK DK715988A patent/DK715988D0/da not_active Application Discontinuation
-
1989
- 1989-12-11 EP EP89122826A patent/EP0374674A2/en not_active Withdrawn
- 1989-12-13 IL IL92681A patent/IL92681A0/xx unknown
- 1989-12-13 CA CA002005354A patent/CA2005354A1/en not_active Abandoned
- 1989-12-18 AU AU46927/89A patent/AU4692789A/en not_active Abandoned
- 1989-12-19 FI FI896095A patent/FI896095A0/fi not_active Application Discontinuation
- 1989-12-20 ZA ZA899779A patent/ZA899779B/xx unknown
- 1989-12-21 NO NO89895194A patent/NO895194L/no unknown
- 1989-12-22 JP JP1331426A patent/JPH02225464A/ja active Pending
- 1989-12-22 PT PT92715A patent/PT92715A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI896095A0 (fi) | 1989-12-19 |
| IL92681A0 (en) | 1990-09-17 |
| DK715988D0 (da) | 1988-12-22 |
| CA2005354A1 (en) | 1990-06-22 |
| EP0374674A2 (en) | 1990-06-27 |
| PT92715A (pt) | 1990-06-29 |
| NO895194L (no) | 1990-06-25 |
| AU4692789A (en) | 1990-06-28 |
| ZA899779B (en) | 1990-09-26 |
| JPH02225464A (ja) | 1990-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO903656L (no) | Fremgangsmaate for fremstilling av 17beta-acyl-4-aza-5alfa-androst-1-en-3-oner. | |
| NO873472D0 (no) | Fremgangsmaate for fremstilling av soetsaker. | |
| NO872831L (no) | Fremgangsmte for fremstilling av nitrofuranderivater. | |
| NO894786D0 (no) | Fremgangsmaate for fremstilling av propenon-oksimetere. | |
| NO895194D0 (no) | Fremgangsmaate for fremstilling av piperidinderivater. | |
| NO885454L (no) | Fremgangsmaate for fremstilling av triklormonosilan. | |
| NO894210L (no) | Fremgangsmaate for fremstilling av kinolyloxazol-2-oner. | |
| NO894649L (no) | Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid. | |
| NO901070D0 (no) | Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater. | |
| NO901832L (no) | Fremgangsmaate for fremstilling av polyketon. | |
| NO895032L (no) | Fremgangsmaate for fremstilling av 2-benzotiazoliner. | |
| NO903780L (no) | Fremgangsmaate til fremstilling av epipodofyllotoksinaltrosid-derivater. | |
| NO890159L (no) | Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler. | |
| NO892021D0 (no) | Fremgangsmaate for fremstilling av pyrrolidinderivater. | |
| IT1237508B (it) | Procedimento per preparare n-fosfonometilglicina. | |
| NO901071L (no) | Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater. | |
| NO885435D0 (no) | Fremgangsmaate for fremstilling av benzotiazepinderivater. | |
| NO871759D0 (no) | Fremgangsmaate for fremstilling av sucralfat-preparater. | |
| NO893713D0 (no) | Fremgangsmaate for fremstilling av benzoksazolon-derivater. | |
| NO870828L (no) | Fremgangsmte for fremstilling av biskarbamater. | |
| NO895040L (no) | Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer. | |
| NO874958D0 (no) | Fremgangsmaate for fremstilling av 1-aryloksy-3-amino-2-propanoler. | |
| NO903196L (no) | Fremgangsmaate for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoater. | |
| NO161779C (no) | Fremgangsmaate for fremstilling av et antiforkjoelsespreparat. | |
| NO883398L (no) | Fremgangsmaate for fremstilling av benzoksazin-derivater. |